Research Article
Stability Indicating HPLC Determination of Risperidone in Bulk Drug and Pharmaceutical Formulations
Table 4
Summary of forced degradation results.
| Sr. no. | Stress/exposure condition | Drug remained/20 g/mL ± SD () | Retention time of degradants | % Recovery | % Degradation |
| (1) | Acid degradation | | 4.20 | 73.10 | 26.89 | (2) | Base degradation | | 2.62 | 82.46 | 17.53 | (3) | Oxidation | | 2.67 | 31.45 | 68.54 | (4) | Thermal degradation | | 2.75 | 69.90 | 30.09 | (5) | Photo degradation | | 2.76 | 73.37 | 26.62 |
|
|